Commerce exempts South Korean biopharma from import tariffs on Sept. 29
New BIS rules grant zero-tariff entry for antibody-drug conjugates and cell therapies from 19 allied jurisdictions, shielding…
Company watch
All companies →Celltrion
Every EAB briefing that touches Celltrion — capital spending, plants, M&A, earnings and policy exposure. 1 briefing.
- First seen
- September 27, 2026
- Latest
- September 27, 2026
- With a linked document
- 1 of 1
- Subject of the briefing
- 1
- Desks
- Semiconductors (1)